metricas
covid
European Journal of Psychiatry Clinical practice and metabolic consequences of olanzapine use in schizophrenia:...
Journal Information

Statistics

Follow this link to access the full text of the article

Clinical practice and metabolic consequences of olanzapine use in schizophrenia: results from a national survey in Spain
L.I. Muñoz-Manchadoa,
Corresponding author
leticia.munoz.sspa@juntadeandalucia.es

Correspondence author. Mental Health Inpatient Unit, University Hospital of Jerez de la Frontera, Trebujena Road, s/n. 11407, Jerez de la Frontera, Cádiz, Spain.
, M. Bernardob, J.M. Villagrán-Morenoa, E. Fernández-Egeac
a Unidad de Gestión clínica de Salud Mental, Área de Gestión Sanitaria Norte de Cádiz, Hospital Universitario de Jerez de la Frontera, Spain. Severe Mental Disorder Research Group, Department of Neuroscience, University of Cádiz. Instituto de Investigación e Innovación Biomédica de Cádiz (INiBICA), Cádiz, Spain
b Emeritus Consultant. Barcelona Clínic Schizophrenia Unit, Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain
c Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom y Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, United Kingdom
Read
Not available
Times
was read the article
Total PDF
Total HTML
Share statistics
Article information
ISSN: 02136163
Original language: English
The statistics are updated each day

Follow this link to access the full text of the article